Search
Research
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.
Smoking + BMI in heart disease
WGS for cardiovascular outcomes
RNA-Seq in pancreatic cancer
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting
Request Access
Overview
Selected Publications (2)
Variables (26)
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.
A. Robidoux, G. Tang, P. Rastogi, et al. (2013). The Lancet. Oncology. Cited 358 times.
https://doi.org/10.1016/S1470-2045(13)70411-X
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer
A. Fernández-Martínez, Mattia Rediti, Gong Tang, et al. (2024). JAMA Oncology. Cited 15 times.
https://doi.org/10.1001/jamaoncol.2023.7304
